A new chapter in pharmaceutical manufacturing: 3D-printed drug products

Advanced Drug Delivery Reviews

Volumn 108, Issue , 2017, Pages 39-50

  Norman, James ^a   Madurawe, Rapti D ^a   Moore, Christine M V ^b   Khan, Mansoor A ^c   Khairuzzaman, Akm ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

3D printed drug products; 3D printing technology; On demand manufacturing; Personalization

Indexed keywords

COMPETITION; DRUG DOSAGE; DRUG PRODUCTS; MANUFACTURE; PRINTING;

3-D PRINTING; ADVANCED MANUFACTURING TECHNOLOGIES; MANUFACTURING FLEXIBILITY; ON DEMANDS; PERSONALIZATIONS; PHARMACEUTICAL MANUFACTURING; PHARMACEUTICAL PROCESS; TRADITIONAL MANUFACTURING;

3D PRINTERS;

DRUG COATING; DRUG MANUFACTURE; ENCAPSULATION; FREEZE DRYING; HUMAN; NANOFABRICATION; PARTICLE SIZE; PELLET EXTRUSION; POLYMERIZATION; POWDER; PROCESS CONTROL; REVIEW; SUSPENSION; TABLET COMPRESSION; TABLET MACHINE; THREE DIMENSIONAL PRINTING; DRUG DESIGN; PHARMACEUTICS;

DRUG DESIGN; HUMANS; PRINTING, THREE-DIMENSIONAL; TECHNOLOGY, PHARMACEUTICAL;

EID: 84961955670     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2016.03.001     Document Type: Review

References (137)

1. [1] Gross, B.C., et al. Evaluation of 3D printing and its potential impact on biotechnology and the chemical sciences. Anal. Chem. 86 (2014), 3240–3253.
2. [2] United States Food and Drug Administration, Highlights of Prescribing Information — Spritam., 2015 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207958s000lbl.pdf.
3. [3] Kolakovic, R., et al. Printing technologies in fabrication of drug delivery systems. Expert Opin. Drug Deliv. 10 (2013), 1711–1723.
4. [4] Moulton, S.E., Wallace, G.G., 3-Dimensional (3D) fabricated polymer based drug delivery systems. J. Control. Release 193 (2014), 27–34.
5. [5] Ursan, I.D., Chiu, L., Pierce, A., Three-dimensional drug printing: a structured review. J. Am. Pharm. Assoc. 53 (2013), 136–144.
6. [6] Ventola, C.L., Medical applications for 3D printing: current and projected uses. P&T 39 (2014), 704–711.
7. [7] Yu, D.G., Zhu, L.M., Branford-White, C.J., Yang, X.L., et al. Three-dimensional printing in pharmaceutics: promises and problems. J. Pharm. Sci. 97 (2008), 3666–3690.
8. [8] Prasad, L.K., Smyth, H., 3D printing technologies for drug delivery: a review. Drug Dev. Ind. Pharm. 13 (2015), 1–13.
9. [9] Katakam, P., Dey, B., Assaleh, F.H., et al. Top-down and bottom-up approaches in 3D printing technologies for drug delivery challenges. Crit. Rev. Ther. Drug Carrier Syst. 32 (2015), 61–87.
10. [10] Jonathan, G., Karim, A., 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int. J. Pharm. 499 (2016), 376–394.
11. [11] United States Code of Federal Regulations — Title 21 — §210.3(b)(4): Definitions — Drug Product. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=210.3.
12. [12] United States Government Accountability Office, 3D Printing: Opportunities, Challenges, and Policy Implications of Additive Manufacturing. 2015 Available from: http://www.gao.gov/assets/680/670960.pdf.
13. [13] Chhaya, M.P., Poh, P.S., Balmayor, E.R., et al. Additive manufacturing in biomedical sciences and the need for definitions and norms. Expert Rev. Med. Devices 12 (2015), 537–543.
14. [14] International Standards Organization. ISO/ASTM 52900 Additive Manufacturing — General Principles — Terminology. [under development] Available from: http://www.iso.org/iso/catalogue_detail.htm?csnumber=69669.
15. [15] Gibson, I., Rosen, D., Stucker, B., Additive Manufacturing Technologies: 3D Printing, Rapid Prototyping, and Direct Digital Manufacturing. second ed., 2015, Springer, New York.
16. [16] United States Food and Drug Administration, Additive Manufacturing of Medical Devices Public Workshop — Transcript for October 8th., 2014 Available from: http://www.fda.gov/downloads/MedicalDevices/NewsEvents/WorkshopsConferences/UCM425399.pdf.
17. [17] Katstra, W.E., et al. Oral dosage forms fabricated by three dimensional printing. J. Control. Release 66 (2000), 1–9.
18. [18] Kastra, W.E., Fabrication of complex oral delivery forms by three dimensional printing™. Dissertation in Materials Science and Engineering, 2001, Massachussetts Institute of Technology.
19. [19] Lipson, H., Kurman, M., Fabricated: The New World of 3D Printing. 2013, John Wiley & Sons, Inc., Indianapolis, IN.
20. [20] Pardeike, J., Strohmeier, D.M., Schrodl, N., et al. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int. J. Pharm. 420 (2011), 93–100.
21. [21] Aulton, M.E., Taylor, K.M.G., Aulton's Pharmaceutics: The Design and Manufacture of Medicines. 2013, Elsevier, Philadelphia.
22. [22] Icten, E., et al. Dropwise additive manufacturing of pharmaceutical products for melt-based dosage forms. J. Pharm. Sci. 104 (2015), 1641–1649.
23. [23] Gao, G., et al. Improved properties of bone and cartilage tissue from 3D inkjet-bioprinted human mesenchymal stem cells by simultaneous deposition and photocrosslinking in PEG-GelMA. Biotechnol. Lett. 37 (2015), 2349–2355.
24. [24] Hirshfield, L., et al. Dropwise additive manufacturing of pharmaceutical products for solvent-based dosage forms. J. Pharm. Sci. 103 (2014), 496–506.
25. [25] Ebert, J., et al. Direct inkjet printing of dental prostheses made of zirconia. J. Dent. Res. 88 (2009), 673–676.
26. [26] Deiner, L.J., Farjami, E., Diffuse reflectance infrared spectroscopic identification of dispersant/particle bonding mechanisms in functional inks. J. Vis. Exp., 99, 2015, e52744.
27. [27] Zhou, W., Loney, D., Fedorov, A.G., Degertekin, F.L., Rosen, D.W., What controls dynamics of droplet shape evolution upon impingement on a solid surface?. AIChE J. 59 (2013), 3071–3082.
28. [28] Lee, B.K., et al. Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system. Int. J. Pharm. 427 (2012), 305–310.
29. [29] Adams, J.J., Duoss, E.B., Malkowski, T.F., et al. Conformal printing of electrically small antennas on three-dimensional surfaces. Adv. Mater. 23 (2011), 1335–1340.
30. [30] Genina, N., et al. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. Eur. J. Pharm. Sci., 2015 (in press, Corrected Proof).
31. [31] Goyanes, A., et al. Fused-filament 3D printing (3DP) for fabrication of tablets. Int. J. Pharm. 476 (2014), 88–92.
32. [32] Khaled, S.A., et al. 3D printing of tablets containing multiple drugs with defined release profiles. Int. J. Pharm. 494 (2015), 643–650.
33. [33] Lewis, J.A., et al. Direct ink writing of three-dimensional ceramic structures. J. Am. Chem. Soc. 89 (2006), 3599–3609.
34. [34] Cho, Y.S., Kim, Y.K., Direct ink writing of quantum dot nanoparticles by robocasting apparatus for precise light-emitting patterns. J. Nanoelectron. Optoelectron. 10 (2015), 114–118.
35. [35] Jin, Y., Plott, J., Shih, A.J., Extrusion-based additive manufacturing of the moisture-cured silicone elastomer. International Solid Freeform Fabrication Symposium, 2015, Laboratory for Freeform Fabrication and the University of Texas, Austin, TX, USA (Available from: http://sffsymposium.engr.utexas.edu/sites/default/files/2015/2015-25-Jin.pdf).
36. [36] Reprap.org. Fused Filament Fabrication. Available from: http://reprap.org/wiki/Fused_filament_fabrication.
37. [37] Reprap.org. Cost Reduction. Available from: http://reprap.org/wiki/Cost_Reduction.
38. [38] Azimi, P., et al. Emissions of ultrafine particles and volatile organic compounds from commercially available desktop three-dimensional printers with multiple filaments. Environ. Sci. Technol. 50 (2016), 1260–1268.
39. [39] Steinle, P., Characterization of emissions from a desktop 3D printer and indoor air measurements in office settings. J. Occup. Environ. Hyg. 13 (2016), 121–132.
40. [40] Kim, Y., et al. Emissions of nanoparticles and gaseous material from 3D printer operation. Environ. Sci. Technol. 20 (2015), 12044–12053.
41. [41] Water, J.J., et al. Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material. J. Pharm. Sci. 104 (2015), 1099–1107.
42. [42] Weisman, J.A., et al. Antibiotic and chemotherapeutic enhanced three-dimensional printer filaments and constructs for biomedical applications. Int. J. Nanomedicine 10 (2015), 357–370.
43. [43] Skowyra, J., Pietrzak, K., Alhnan, M.A., Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur. J. Pharm. Sci. 68 (2015), 11–17.
44. [44] Goyanes, A., et al. Effect of geometry on drug release from 3D printed tablets. Int. J. Pharm. 495 (2015), 657–663.
45. [45] Goyanes, A., et al. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur. J. Pharm. Biopharm. 89 (2015), 157–162.
46. [46] Goyanes, A., et al. 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol. Pharm. 12 (2015), 4077–4084.
47. [47] Kruth, J.P., et al. Binding mechanisms in selective laser sintering and selective laser melting. Rapid Prototyp. J. 11 (2005), 26–36.
48. [48] Hopkinson, N., 2009 Innovation: high-speed sintering. Manuf. Eng. 143 (2009), 15–16.
49. [49] Ellis, A., Noble, C.J., Hartley, L., et al. Materials for high speed sintering. J. Mater. Res. 29 (2014), 2080–2085.
50. [50] Leong, K.F., et al. Building porous biopolymeric microstructures for controlled drug delivery devices using selective laser sintering. Int. J. Adv. Manuf. Technol. 31 (2006), 483–489.
51. [51] Melchels, F.P., Feijen, J., Grijpma, D.W., A review on stereolithography and its applications in biomedical engineering. Biomaterials 31 (2010), 6121–6130.
52. [52] Tumbleston, J.R., et al. Additive manufacturing. Continuous liquid interface production of 3D objects. Science 347 (2015), 1349–1352.
53. [53] Kim, R.H., Lee, K.-S., 3D stereolithography using two-photon polymerization. Macromol. Symp. 298 (2010), 25–33.
54. [54] Xing, J.F., Zheng, M.L., Duan, X.M., Two-photon polymerization microfabrication of hydrogels: an advanced 3D printing technology for tissue engineering and drug delivery. Chem. Soc. Rev. 44 (2015), 5031–5039.
55. [55] Han, Y.L., et al. BioPen: direct writing of functional materials at the point of care. Sci. Rep., 4, 2004, 4872.
56. [56] Boehm, R.D., et al. Indirect rapid prototyping of antibacterial acid anhydride copolymer microneedles. Biofabrication, 4, 2012, 011002.
57. [57] Ochoa, M., Zhou, J., Rahimi, R., et al. Rapid 3D-print-and-shrink fabrication of biodegradable microneedles with complex geometries. Solid-state Sensors, Actuators and Microsystems, 2015, IEEE, Piscataway, NJ, USA (Anchorage, AK. Available from: http://ieeexplore.ieee.org/xpl/login.jsp?tp=&arnumber=7181157&url=http%3A%2F%2Fieeexplore.ieee.org%2Fxpls%2Fabs_all.jsp%3Farnumber%3D7181157).
58. [58] Rutledge, G.C., Fridrikh, S.V., Formation of fibers by electrospinning. Adv. Drug Deliv. Rev. 59 (2007), 1384–1391.
59. [59] Blakney, A.K., et al. Electrospun fibers for vaginal anti-HIV drug delivery. Antivir. Res. 100:Suppl (2013), S9–16.
60. [60] Luo, G., et al. Direct-write, self-aligned electrospinning on paper for controllable fabrication of three-dimensional structures. ACS Appl. Mater. Interfaces 7:50 (2015), 27765–27770.
61. [61] Ortega, I., et al. Fabrication of biodegradable synthetic perfusable vascular networks via a combination of electrospinning and robocasting. Biomater. Sci. 3 (2015), 592–596.
62. [62] Hiller, J., Lipson, H., Design and analysis of digital materials for physical 3D voxel printing. Rapid Prototyp. J. 15 (2009), 137–149.
63. [63] Snyder, T.J., et al. 3D systems' technology overview and new applications in manufacturing, engineering, science, and education. 3D Print. Addit. Manuf. 1 (2014), 169–176, 10.1089/3dp.2014.1502.
64. [64] University of Southern California. Contour Crafting — How Does It Work? Available from: http://www.contourcrafting.org/how-does-it-work/.
65. [65] Deng, D., Chen, Y., Assembled additive manufacturing — a hybrid fabrication process inspired by origami design. International Solid Freeform Fabrication Symposium, 2013, Laboratory for Freeform Fabrication and the University of Texas, Austin, TX, USA (Available from: http://sffsymposium.engr.utexas.edu/Manuscripts/2013/2013-14-Chen.pdf).
66. [66] Gao, W., et al. RevoMaker: enabling multi-directional and functionally-embedded 3D printing using a rotational cuboidal platform. Proceedings of the 28th Annual ACM Symposium on User Interface Software & Technology, 2015, ACM, New York, NY, USA (Available from: http://dl.acm.org/citation.cfm?id=2807476).
67. [67] Vaezi, M., Seitz, H., Yang, S., A review of 3D micro-additive manufacturing technologies. Int. J. Adv. Manuf. Technol. 67 (2013), 1721–1754.
68. [68] Kawata, S., et al. Finer features for functional microdevices. Nature 412 (2001), 697–698.
69. [69] Nanoscribe. High-speed printing of 3D micro- and nanostructures. Available from: http://www.nanoscribe.de/en/media-press/newsletter/march-2013/photonic-professional-gt/.
70. [70] Lee, M., Kim, H.Y., Toward nanoscale three-dimensional printing: nanowalls built of electrospun nanofibers. Langmuir 30 (2014), 1210–1214.
71. [71] Borovicka, J., et al. Photothermal colloid antibodies for shape-selective recognition and killing of microorganisms. J. Am. Chem. Soc. 135 (2013), 5282–5285.
72. [72] IBM. Ninja polymers: nanomedicine that can destroy antibiotic-resistant bacteria. Available from: http://www.research.ibm.com/articles/nanomedicine.shtml#fbid=75-0RnDFXK9.
73. [73] Zhang, Q., et al. Pattern transformation of heat-shrinkable polymer by three-dimensional (3D) printing technique. Sci. Rep., 5, 2015, 8936.
74. [74] da Silva Bartolo, P.J., “Functionally graded rapid prototyping” in innovative developments in virtual and physical prototyping. Proceedings of the 5th International Conference on Advanced Research in Virtual and Rapid Prototyping, 2011, CRC Press, Boca Raton, FL.
75. [75] Yu, D.G., Tablets with material gradients fabricated by three-dimensional printing. J. Pharm. Sci. 96 (2007), 2446–2456.
76. [76] Ma, L., et al. Using design of experiments in finite element modeling to identify critical variables for laser powder bed fusion. International Solid Freeform Fabrication Symposium, 2015, Laboratory for Freeform Fabrication and the University of Texas, Austin, TX, USA (Available from: http://sffsymposium.engr.utexas.edu/sites/default/files/2015/2015-18-Ma.pdf).
77. [77] Diller, T.T., et al. Thermal model and measurements of polymer laser sintering. Rapid Prototyp. J. 21 (2015), 2–13.
78. [78] Flood, A., Liou, F., Modeling of powder bed processing — a review. International Solid Freeform Fabrication Symposium, 2015, Laboratory for Freeform Fabrication and the University of Texas, Austin, TX, USA (Available from: http://sffsymposium.engr.utexas.edu/sites/default/files/2015/2015-92-Flood.pdf).
79. [79] United States Food and Drug Administration, Guidance for Industry: Q8(R2) Pharmaceutical Development., 2009 Available from: http://www.fda.gov/downloads/Drugs/…/Guidances/ucm073507.pdf.
80. [80] United States Food and Drug Administration, Guidance for Industry: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance., 2015 Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm070305.pdf.
81. [81] National Institute of Standards and Technology, Internal Report 8036 — Measurement Science Needs for Real-time Control of Additive Manufacturing Powder Bed Fusion Processes., 2015 Available from: http://nvlpubs.nist.gov/nistpubs/ir/2015/NIST.IR.8036.pdf.
82. [82] Melendez, P.A., et al. Thermal inkjet application in the preparation of oral dosage forms: dispensing of prednisolone solutions and polymorphic characterization by solid-state spectroscopic techniques. J. Pharm. Sci. 97 (2008), 2619–2636.
83. [83] Vakili, H., et al. Hyperspectral imaging in quality control of inkjet printed personalised dosage forms. Int. J. Pharm. 483 (2015), 244–249.
84. [84] Sandler, N., et al. Rapid interferometric imaging of printed drug laden multilayer structures. Sci. Rep., 4, 2014, 4020.
85. [85] Cerniglia, D., et al. Inspection of additive-manufactured layered components. Ultrasonics 62 (2015), 292–298.
86. [86] Jackson, W.A., From electuaries to enteric coating: a brief history of dosage forms. Anderson, S., (eds.) Making Medicines: A Brief History of Pharmacy and Pharmaceuticals, 2005, Pharmaceutical Press, London.
87. [87] Anderson, S., Making Medicines: A Brief History of Pharmacy and Pharmaceuticals. 2005, Pharmaceutical Press, London, 210–211.
88. [88] Wu, B.M., et al. Solid free-form fabrication of drug delivery devices. J. Control. Release 40 (1996), 77–87.
89. [89] GlaxoSmithKline. Liquid Dispensing Technology (LDT). Available from: https://www.gsk.com/media/279688/liquid-dispensing-technology-leaflet.pdf.
90. [90] Thiel, W.J., et al. Content uniformity of microdose tablets (dosage 1 microgram–10 mg) produced by fluid bed granulation of interactive mixtures. J. Pharm. Pharmacol. 38 (1986), 335–343.
91. [91] Genina, N., et al. Fabrication of printed drug delivery systems. IS&T Reporter, 28, 2013, 236.
92. [92] Rowe, C.W., Multimechanism oral dosage forms fabricated by three dimensional printing. J. Control. Release. 66 (2000), 11–17.
93. [93] Khaled, S.A., Burley, J.C., Alexander, M.R., Roberts, C.J., et al. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int. J. Pharm. 461 (2014), 105–111.
94. [94] Sun, Y., Soh, S., Printing tablets with fully customizable release profiles for personalized medicine. Adv. Mater. 27:47 (2015), 7847–7853.
95. [95] Rattanakit, P., et al. Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms. Int. J. Pharm. 422 (2012), 254–263.
96. [96] Gbureck, U., et al. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J. Control. Release. 122 (2007), 173–180.
97. [97] Huang, W.D., et al. Levofloxacin implants with predefined microstructure fabricated by three-dimensional printing technique. Int. J. Pharm. 339 (2007), 33–38.
98. [98] Sandler, N., et al. Towards fabrication of 3D printed medical devices to prevent biofilm formation. Int. J. Pharm. 459 (2014), 62–64.
99. [99] Wu, W., et al. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy. Biomed. Mater., 4, 2009, 065005.
100. [100] Inzana, J.A., et al. 3D printed bioceramics for dual antibiotic delivery to treat implant-associated bone infection. Eur. Cell Mater. 30 (2015), 232–247.
101. [101] Gupta, M.K., et al. 3D printed programmable release capsules. Nano Lett. 15 (2015), 5321–5329.
102. [102] Huang, T.Y., et al. 3D printed microtransporters: compound micromachines for spatiotemporally controlled delivery of therapeutic agents. Adv. Mater. 27 (2015), 6644–6650.
103. [103] Vehse, M., et al. Drug delivery from poly(ethylene glycol) diacrylate scaffolds produced by DLC based micro-stereolithography. Macromol. Symp. 346 (2014), 43–47.
104. [104] Costa, P.F., et al. Additive manufacturing of scaffolds with dexamethasone controlled release for enhanced bone regeneration. Int. J. Pharm., 2015 (Online publication ahead of print).
105. [105] Bayarri, L., Drug-device combination products: regulatory landscape and market growth. Drugs Today 51 (2015), 505–513.
106. [106] United States Food and Drug Administration, Highlights of Prescribing Information — Herceptin (Initial U.S. Approval., 1998 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103792s5250lbl.pdf.
107. [107] United States Food and Drug Administration, Paving the Way for Personalized Medicine: FDA's Role in a New Era of Medical Product Development., 2013 Available from: http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/PersonalizedMedicine/UCM372421.pdf.
108. [108] Wening, K., Breitkreutz, J., Oral drug delivery in personalized medicine: unmet needs and novel approaches. Int. J. Pharm. 404 (2011), 1–9.
109. [109] Sanderson, K., 3D Printing and Its Pharmaceutical Application, in IFWP Focus. 2015.
110. [110] Sandler, N., et al. Inkjet printing of drug substances and use of porous substrates—towards individualized dosing. J. Pharm. Sci. 100 (2011), 3386–3395.
111. [111] Linares, O.A., et al. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness. Pain Med. 15 (2014), 791–806.
112. [112] Mondal, D., et al. Pharmacogenomics dictate pharmacokinetics: polymorphisms in drug-metabolizing enzymes and drug-transporters. Noreddin, A., (eds.) Readings in Advanced Pharmacokinetics — Theory, Methods and Applications, 2012 (Published online, open access. Available from: http://www.intechopen.com/books/readings-in-advanced-pharmacokinetics-theory-methods-and-applications).
113. [113] Zopf, D.A., et al. Bioresorbable airway splint created with a three-dimensional printer. N. Engl. J. Med. 368 (2013), 2043–2045.
114. [114] Park, S.A., et al. In vivo evaluation and characterization of a bio-absorbable drug-coated stent fabricated using a 3D-printing system. Mater. Lett. 141 (2015), 355–358.
115. [115] Shi, D., et al. Applications of three-dimensional printing technology in the cardiovascular field. Intern. Emerg. Med. 10 (2015), 769–780.
116. [116] Jonas, O., et al. An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors. Sci. Transl. Med., 7(284), 2015, 284ra257.
117. [117] University College London — School of Pharmacy, 3D printed animal-shaped tablets for children., 2015 Available from: https://www.ucl.ac.uk/pharmacy/pharmacy-news/animal-shaped-tablets.
118. [118] Osterberg, L., Blaschke, T., Adherence to medication. N. Engl. J. Med. 353 (2005), 487–497.
119. [119] Srai, J.S., et al. Future supply chains enabled by continuous processing—opportunities and challenges. May 20–21, 2014 Continuous manufacturing symposium J. Pharm. Sci., 104, 2015, 840–849.
120. [120] Skardal, A., et al. Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds. Stem. Cells. Transl. Med. 1 (2012), 792–802.
121. [121] Pwc. The road ahead for 3-D printers. Available from: http://www.pwc.com/us/en/technology-forecast/2014/3d-printing/features/future-3d-printing.html.
122. [122] Melocchi, A., et al. 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs. J. Drug Delivery Sci. Technol. 30 (2015), 360–367.
123. [123] Scoutaris, N., et al. Inkjet printing as a novel medicine formulation technique. J. Control. Release 156 (2011), 179–185.
124. [124] Kitson, P.J., et al. Combining 3D printing and liquid handling to produce user-friendly reactionware for chemical synthesis and purification. Chem. Sci. 4 (2013), 3099–3103.
125. [125] Li, J., et al. Synthesis of many different types of organic small molecules using one automated process. Science 347 (2015), 1221–1226.
126. [126] Symes, M.D., et al. Integrated 3D-printed reactionware for chemical synthesis and analysis. Nat. Chem. 4 (2012), 349–354.
127. [127] Morrison, R.J., et al. Regulatory considerations in the design and manufacturing of implantable 3D-printed medical devices. Clin. Transl. Sci. 8 (2015), 594–600.
128. [128] Blazincic, M., Physics of Ink-Jet Printing., 2008 Available from: http://mafija.fmf.uni-lj.si/seminar/files/2007_2008/physics_of_inkjet_printing.pdf.
129. [129] Holman, R.K., et al. Spreading and infiltration of inkjet-printed polymer solution droplets on a porous substrate. J. Colloid Interface Sci. 249 (2002), 432–440.
130. [130] Aho, J., et al. Rheology as a tool for evaluation of melt processability of innovative dosage forms. Int. J. Pharm. 494 (2015), 623–642.
131. [131] Shah, S., et al. Melt extrusion with poorly soluble drugs. Int. J. Pharm. 453 (2013), 233–252.
132. [132] United States Food and Drug Administration, Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances., 2000 Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm134966.htm.
133. [133] Meyer, B., Accuracy in additive manufacturing. Mach. Des. 84 (2012), 56–62.
134. [134] Bauereiss, A., Scharowsky, T., Korner, C., Defect generation and propagation mechanism during additive manufacturing by selective beam melting. J. Mater. Process. Technol. 214 (2014), 2522–2528.
135. [135] Hirshfield, L., et al. Automation and control of drug-on-demand technology. Annual Meeting of the American Institute of Chemical Engineers, 2012, AIChE, New York, NY, USA (Pittsburgh, PA. Avaialble from: http://www.aiche.org/academy/videos/conference-presentations/automation-and-control-drug-on-demand-technology-0).
136. [136] Goyanes, A., et al. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Int. J. Pharm., 2015 (Online publication ahead of print).
137. [137] Sculpteo. Comparison between 3D printing and traditional manufacturing processes for plastics. Available from: http://www.sculpteo.com/en/3d-printing-and-traditional-manufacturing-processes/.